The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Abstract
Increased plasma levels of triglycerides (TG) in very low density lipoproteins (VLDL) are not only common characteristics of the dyslipidemia associated with insulin resistance and type 2 diabetes mellitus (T2DM) but are the central pathophysiologic feature of the abnormal lipid profile. Overproduction of VLDL leads to increased plasma levels of TG which, via an exchange process mediated by cholesterol ester transfer protein (CETP), results in low levels of high density lipoprotein (HDL) cholesterol and apolipoprotein A-I, and the generation of small, dense, cholesterol ester depleted low density lipoproteins (LDL). Increased assembly and secretion of VLDL by the liver results from the complex, post-transcriptional regulation of apolipoprotein B (apoB) metabolism in the liver. In the presence of low levels of hepatic TG and cholesterol, much of the constitutively synthesized apoB is degraded by both proteasomal and non-proteasomal pathways. When excess TG, and to a lesser extent, cholesterol, are present, and in the presence of active microsomal triglycerides transfer protein, apoB is targeted for secretion. The major sources of TG in the liver: uptake of fatty acids (FA) released by lipolysis of adipose tissue TG, uptake of TGFA in VLDL and chylomicrons remnants, and hepatic de novo lipogenesis (the synthesis of FA from glucose) are all abnormally increased in insulin resistance. Treatment of the dyslipidemia in insulin resistant individuals and patients with T2DM has been successful in reducing cardiovascular disease; LDL cholesterol, TG, and HDL cholesterol are all appropriate targets for therapy when diet, exercise, and weight loss do not achieve goals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These neuroendocrine factors also stimulate adipose lipolysis which releases free fatty acids into the circulation and leads to dyslipidemia96.”
From Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health (2021) · cites this paper as [96]
Citations
Cites
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Self-citationDiabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Steiner, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04209-4 · Cited by 849
Research works printed but not linked: 2
- Ginsberg, 1998, Lipoprotein physiology. Chapter 1
- Taghibiglou, 2002, Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance, J Biol Chem, 277, 793, 10.1074/jbc.M106737200 · DOI
Cited by
Sorted by citations
Items 201–300 of 530
Cui, J., Sun, J., Wang, W., Xin, H., Qiao, Q., Baloch, Z., & Ma, A. (2017) · Oncotarget · doi:10.18632/oncotarget.21969 · Cited by 24
Yang, X., Gao, Z., Huang, X., Zhang, M., Shi, Y., & Chen, Z. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02685-8 · Cited by 24
Nutritional management of hyperlipaemia
Durham, A. E., & Thiemann, A. (2015) · Equine Veterinary Education · doi:10.1111/eve.12366 · Cited by 25
Dayspring, T. D. (2011) · International Journal of Women s Health · doi:10.2147/ijwh.s16702 · Cited by 25
da Rosa, F. T., Osorio, J. S., Trevisi, E., Yanqui-Rivera, F., Estill, C. T., & Bionaz, M. (2017) · PPAR Research · doi:10.1155/2017/7097450 · Cited by 23
Ahmed, F., Al‐Habori, M., Al-Zabedi, E., & Saif-Ali, R. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00788-5 · Cited by 26
Plasma Levels of Triglycerides and IL-6 Are Associated With Weight Regain and Fat Mass Expansion
Qiao, Q., Bouwman, F. G., van Baak, M. A., Roumans, N. J. T., Vink, R., & Mariman, E. C. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac198 · Cited by 23
Insulin resistance and lipid disorders
Miccoli, R., Keyzer, D. D., Penno, D. G., & Prato, D. S. D. (2008) · Future Lipidology · doi:10.2217/17460875.3.6.651 · Cited by 24
Diabetic dyslipidemia or ‘diabetes lipidus’?
Muačević‐Katanec, D., & Reiner, Ž. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.17 · Cited by 23
Different regulation of insulin on glucose and lipid metabolism in 2 strains of gibel carp
Jin, J., Zhu, X., Han, D. H., Yang, Y., Liu, H., & Xie, S. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.01.012 · Cited by 22
Sokup, A., Góralczyk, B., Góralczyk, K., & Rość, D. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01289.x · Cited by 22
Wu, X., Li, Y., Wang, Q., Li, W., & Feng, Y. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.11.008 · Cited by 22
Faraj, M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190124 · Cited by 23
Lee, M.-K., Han, K., Kim, M. K., Koh, E. S., Kim, E. S., Nam, G. E., Hong, O., Kim, B., & Kwon, H. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108237 · Cited by 21
Yao, X., Pei, X., Fan, S., Yang, X., Yang, Y., & Li, Z. (2022) · Scientific Reports · doi:10.1038/s41598-022-13164-7 · Cited by 21
Maki, K. C., Lawless, A. L., Kelley, K., Dicklin, M. R., Schild, A. L., & Rains, T. M. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.06.005 · Cited by 21
Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury
Oyama, Y., Walker, L. A., & Eckle, T. D. L. G. (2021) · Chronobiology International · doi:10.1080/07420528.2021.1928160 · Cited by 19
Roles of Fatty Acid Oversupply and Impaired Oxidation in Lipid Accumulation in Tissues of Obese Rats
Oakes, N. D., Kjellstedt, A., Thalén, P., Ljung, B., & Turner, N. A. (2013) · Journal of Lipids · doi:10.1155/2013/420754 · Cited by 21
Scalioni, L. D. P., dos Santos, B. R., Spritzer, P. M., Villela‐Nogueira, C. A., Lewis‐Ximenez, L. L., Pollo‐Flores, P., Esberard, E. B. C., Brandão‐Mello, C. E., Lampe, E., & Villar, L. M. (2018) · Medicine · doi:10.1097/md.0000000000009881 · Cited by 20
Fujimoto, B., Young, M., Nakamura, N., Ha, H. Y., CARTER, L. T., Pitts, M. W., Torres, D. J., Noh, H. L., Suk, S., Kim, J. K., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100482 · Cited by 20
Fatty Acids and Insulin Resistance: A Perfect Storm
Koo, S., & Montminy, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.001 · Cited by 20
Novaković, T., Mekić, M., Smilic, L., Smilic, T. N., Ini, B., Kostic, K., Jovićević, L., Mirković, Z., & Milinić, S. (2014) · Medical Archives · doi:10.5455/medarh.2014.68.22-26 · Cited by 20
López-Ríos, L., Pérez-Jiménez, P., Martínez‐Quintana, E., Rodríguez-González, F. G., Díaz-Chico, B. N., Novoa, F. J., Serra‐Majem, L., & Chirino, R. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.06.009 · Cited by 20
Kim, S.-H., Song, Y. H., Park, S., & Park, M.-J. (2016) · Korean Journal of Pediatrics · doi:10.3345/kjp.2016.59.2.65 · Cited by 20
Harfmann, B. D., Schroder, E. A., England, J. H., Senn, N. J., Westgate, P. M., Esser, K. A., & Kern, P. A. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00086 · Cited by 16
Petrosyan, L. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.02.004 · Cited by 19
Zhang, J., Jazii, F. R., Haghighi, M. M., ALVARES, D. C. L., Liu, L., Khosraviani, N., & Adeli, K. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00276.2019 · Cited by 19
Effects of fullerene C60 supplementation on gut microbiota and glucose and lipid homeostasis in rats
Đurašević, S., Nikolić, G., Todorović, A., Drakulić, D., Pejić, S., Martinović, V., Mitić-Ćulafić, D., Milić, D. R., Kop, T. J., Jasnic, N. I., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111302 · Cited by 20
Monteiro‐Alfredo, T., Oliveira, S., Amaro, A., Silva, D., Antunes, K. Á., Pires, A. S., Teixo, R. J., Abrantes, A. M., Botelho, M. F., Castelo-Branco, M. S., et al. (2021) · Nutrients · doi:10.3390/nu13082856 · Cited by 19
Lester, S. G., Russo, L., Ghanem, S. S., Khuder, S. S., DeAngelis, A. M., Esakov, E. L., Bowman, T. A., Heinrich, G., Al–Share, Q. Y., McInerney, M. F., et al. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00116 · Cited by 19
Zhang, C., Yao, M., Wang, X., Zhuang, Y., Xia, Z., Yang, Y., Li, Y., Liu, X., Li, K., & Wang, J. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.04.016 · Cited by 19
Emerging antidyslipidemic drugs
Pollex, R. L., JOY, T. R., & Hegele, R. A. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.2.363 · Cited by 19
Alssema, M., Dekker, J. M., Kuivenhoven, J. A., Nijpels, G., Teerlink, T., Scheffer, P. G., Diamant, M., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02033.x · Cited by 19
Appiah, C. A., Afriyie, E. O., Hayford, F. E. A., & Frimpong, E. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.36.136.16861 · Cited by 18
Cho, A., Kwon, Y., & Kim, J.-K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080700 · Cited by 18
Chen, Y., Xu, C., Zhang, J., Zeng, C., Wang, X.-F., Zhou, R. L., Xu, L., Ao, Z., Lu, J., Shen, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201173 · Cited by 18
Ramchoun, M., Khouya, T., Harnafi, H., Amrani, S., Alem, C., Benlyas, M., Kasbi-Chadli, F., Nazih, H., Nguyen, P., & Ouguerram, K. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3282596 · Cited by 18
Smits, A., Marei, W. F. A., Neubourg, D. D., & Leroy, J. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00848-4 · Cited by 18
Metabolic Syndrome in Children and Adolescents
Chung, L. Y., & Rhie, Y. (2022) · Ewha Medical Journal · doi:10.12771/emj.2022.e13 · Cited by 23
From worms to humans: Understanding intestinal lipid metabolism via model organisms
Kozan, D. W., Derrick, J. T., Ludington, W. B., & Farber, S. A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159290 · Cited by 17
Mechanism of action for small-molecule inhibitors of triacylglycerol synthesis
Sui, X., Wang, K., Song, K., Xu, C., Song, J., Lee, C., Liao, M., Farese, R. V., & Walther, T. C. (2023) · Nature Communications · doi:10.1038/s41467-023-38934-3 · Cited by 17
Ward, A., Dail, M. B., & Chambers, J. E. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.08.011 · Cited by 17
Bissonnette, S., Saint-Pierre, N., Lamantia, V., Leroux, C., Provost, V., Cyr, Y., RABASA-LHORET, R. P. R., & Faraj, M. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy070 · Cited by 16
Tripathy, J. P., Thakur, J. S., Jeet, G., & Jain, S. (2018) · Tropical Medicine and Health · doi:10.1186/s41182-018-0104-y · Cited by 17
Majaw, S., Challam, S., & Syiem, D. (2018) · Journal of Morphological Sciences · doi:10.1055/s-0038-1669934 · Cited by 17
Omolekulo, T. E., Michael, O. S., & Olatunji, L. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.036 · Cited by 17
Physiological and pathophysiological actions of insulin in the liver
Kubota, N., Kubota, T., & Kadowaki, T. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0192 · Cited by 19
Moriyama, K. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i29.108380 · Cited by 26
Sun, Y., & Kosmas, P. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3472077 · Cited by 19
Riediger, N. D., Clark, K. O., Lukianchuk, V., Roulette, J., & Bruce, S. G. (2017) · International Journal of Circumpolar Health · doi:10.1080/22423982.2017.1310444 · Cited by 16
Mungamuri, S. K., Sinha, S. N., & Javvadi, Y. (2020) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2020035839 · Cited by 17
Zhao, M., Qin, J., Shen, W., & Wu, A. (2021) · BioMed Research International · doi:10.1155/2021/8835408 · Cited by 17
Majeed, F., & Miller, M. J. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f79b0b · Cited by 16
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 15
Yuan, G., Liu, Y., Sun, T., Xu, Y., Zhang, J., Yang, Y., Zhang, M., Cianflone, K., & Wang, D. W. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.038 · Cited by 15
Xu, Y., Bao, Q., He, B., Pan, Y., Zhang, R., Mao, X., Tang, Z., Qu, L., Zhu, C., Tian, F., et al. (2012) · PubMed · doi:10.3275/7797 · Cited by 15
Nantermet, P. V., Harada, S.-I., Liu, Y., Cheng, S., Johnson, C. A., Yu, Y., Kimme, D., Holder, D., Hodor, P. G., Phillips, R., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1151 · Cited by 15
The Effects of Several Halophytes on Insulin Resistance in Otsuka Long-evans Tokushima Fatty Rats
Cho, J., Huang, Z., Park, S.-Y., Park, K., Pai, T.-K., Kim, S.-Y., Kim, H.-R., & Ham, K. (2014) · Korean Journal of Food Science and Technology · doi:10.9721/kjfst.2014.46.1.100 · Cited by 14
Awaad, A. K., Kamel, M. A. E.-N., Mohamed, M. M., Helmy, M. H., Youssef, M. I., Zaki, E. I., Essawy, M. M., & Hegazy, M. G. A. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00046-8 · Cited by 14
Nikołajuk, A., Karczewska‐Kupczewska, M., & Strączkowski, M. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0164 · Cited by 14
Treatment of the Dyslipidemia of Insulin Resistance
Smith, D. A. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.008 · Cited by 14
Kwon, Y. H., Kim, S.-K., Cho, J. H., Kwon, H., Park, S. E., Oh, H.-G., Park, C., Lee, W., Oh, K. W., Park, S., et al. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.1.55 · Cited by 14
He, M., Sun, M., Koval, S., Wijk, R. V., Hankemeier, T., van der Greef, J., Wijk, E. P. A. V., & Wang, M. (2019) · Engineering · doi:10.1016/j.eng.2019.03.011 · Cited by 14
Association between Dyslipidemia and Vitamin D Deficiency: a Cross-Sectional Study
Sharba, Z. F., Shareef, R. H., Abd, B. A., & Hameed, E. N. (2021) · Folia Medica · doi:10.3897/folmed.63.e62417 · Cited by 13
Hansel, B., Kontush, A., Giral, P., Bonnefont‐Rousselot, D., Chapman, M. J., & Bruckert, É. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104821 · Cited by 13
Actividad física en la prevención y tratamiento de la obesidad infantil
Ximena Raimann, T., & Francisco, V. M. (2012) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(12)70304-8 · Cited by 13
Alssema, M., Schindhelm, R. K., Dekker, J. M., Diamant, M., Nijpels, G., Teerlink, T., Scheffer, P. G., Kostense, P. J., & Heine, R. J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.04.022 · Cited by 13
Krizhanovskii, C., Ntika, S., Olsson, C., Eriksson, P. O., & Franco‐Cereceda, A. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0279-0 · Cited by 13
Yang, W., Pang, N., & He, X. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02693-5 · Cited by 14
Das, S., Sakr, H. F., Sirasanagandla, S. R., Bima, A. I. H., & Elsamanoudy, A. Z. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220511121629 · Cited by 13
Meng, W., Brigance, R. P., Mignone, J., Negash, L., Zhao, G., Ahmad, S., Wang, W., Moore, F., Ye, X., Sun, J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01147 · Cited by 12
Kim, M., & Kobori, T. (2023) · Nutrients · doi:10.3390/nu15234955 · Cited by 15
Meng, T., Kubow, S. J., & Nielsen, D. E. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00766-w · Cited by 12
He, W., Mori, M., Yu, X., & Kanda, T. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-015-0168-1 · Cited by 12
Kim, M., Seol, M. H., & Lee, B.-C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122858 · Cited by 12
Spadaccini, D., Perna, S., Peroni, G., D’Antona, G., Iannello, G., Faragli, A., Infantino, V., Riva, A., Petrangolini, G., Negro, M., et al. (2020) · Life · doi:10.3390/life10090163 · Cited by 13
Aronis, K. N., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.001 · Cited by 12
Berk, K. A., Vongpromek, R., Jiang, M., Schneider, W. J., Timman, R., Verhoeven, A. J. M., Bujo, H., Sijbrands, E. J. G., & Mulder, M. T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.066 · Cited by 12
Lai, F., Li, Z., Yue, S., Pei, L., Xiao, H., Li, Z., Li, Y., Xiao, H., & Cao, X. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01519-4 · Cited by 11
Ru, Z., Hu, J., Li, Y., Chen, X., Wang, Q., Wu, T., Zhou, W., Bi, Y., Shen, S., & Ge, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1545393 · Cited by 11
Wang, W., Khan, S. H., Blackett, P. R., Alaupovic, P., & Lee, E. T. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.06.007 · Cited by 11
Forrester, J., McGovern, B., Rhee, M., & Sterling, R. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00722.x · Cited by 11
Mechanisms of Incretin Effects on Plasma Lipids and Implications for the Cardiovascular System
Xiao, C., Dash, S., & Lewis, G. F. (2012) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152512803530315 · Cited by 11
Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice
Bağcı, R., Şahıntürk, V., & Şahin, E. (2019) · Tissue and Cell · doi:10.1016/j.tice.2019.07.001 · Cited by 11
Alanazi, A. Z., Al-Rejaie, S. S., Ahmed, M. M., Alhazzani, K., Alhosaini, K. A., Sobeai, H. M. A., Alsanea, S., Alam, P., Almarfadi, O. M., Alqahtani, A. S., et al. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.06.002 · Cited by 11
Adolescent and adult African Americans have similar metabolic dyslipidemia
Gidding, S. S., Keith, S. W., & Falkner, B. E. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.11.010 · Cited by 11
Yoshinaga, M., Takahashi, H., Shinomiya, M., Miyazaki, A., Kuribayashi, N., & Ichida, F. (2010) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.5264 · Cited by 13
Gutaj, P., Zawiejska, A., Brązert, J., & Wender-Ożegowska, E. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2830 · Cited by 11
A lipidome-wide association study of the lipoprotein insulin resistance index
Bagheri, M., Tiwari, H. K., Murillo, A. L., Al-Tobasei, R., Arnett, D. K., Kind, T., Barupal, D. K., Fan, S., Fiehn, O., O’Connell, J. R., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01321-8 · Cited by 11
Leiter, L. A., & FITCHETT, D. H. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.01.006 · Cited by 11
Carbohydrate restriction and cardiovascular risk
Karam, J. G., Nessim, F., McFarlane, S. I., & Feinman, R. D. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0018-z · Cited by 11
Effect of Dietary Carbohydrate Restriction With and Without Weight Loss on Atherogenic Dyslipidemia
Wood, R. J. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00187.x · Cited by 11
Dyslipidemia in Chronic Kidney Disease
Streja, E., & Streja, D. A. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch34 · Cited by 11
Sex-specific differences in plasma lipid profiles are associated with Gulf War Illness
Oberlin, S., Nkiliza, A., Parks, M., Evans, J. E., Klimas, N. G., Keegan, A. P., Sullivan, K. A., Krengel, M., MULLAN, M. J., Crawford, F., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03272-3 · Cited by 10
Wani, K., Khattak, M. N. K., Saadawy, G. M., Al-Attas, O. S., Alokail, M. S., & Al‐Daghri, N. M. (2023) · Diagnostics · doi:10.3390/diagnostics13020324 · Cited by 10
Ozcariz, E., Guardiola, M., Amigó, N., Rojo‐Martínez, G., Valdés, S., Rehues, P., Masana, L., & Ribalta, J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110772 · Cited by 10
Tang, L., Mei, X., Ye, M., Liu, Y., Huang, Y., Yu, J., Zhang, L., Zhuge, S., Jiang, G. Z., & Zhu, J. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231223644 · Cited by 10
Body Mass Index and Cardiovascular Risk Markers: A Large Population Analysis
Asztalos, B. F., Russo, G. T., He, L., & Diffenderfer, M. R. (2025) · Nutrients · doi:10.3390/nu17050740 · Cited by 10
Anderson, B. J., Curtis, A. M., Jen, A., Thomson, J. A., Clegg, D., Jiang, P., Coon, J. J., Overmyer, K. A., & Toh, H. (2023) · Lab Animal · doi:10.1038/s41684-023-01268-0 · Cited by 10
Natarajan, V., & Smith, A. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60071-6 · Cited by 10
Metadata
- Authors
- Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A.
- Affiliations
- Columbia University (US)
- Corresponding author
- Ginsberg, Henry N.
- ORCID
- Ginsberg, Henry N.
- Venue
- Archives of Medical Research
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 36
- Issue
- 3
- Pages
- 232-240
- ISSN
- 0066-6769 (ISSN-L)
- 0188-4409
- OpenAlex
- W2095612977
- Cited by
- 531
- References
- 57
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 24 · 2023: 27 · 2022: 26 · 2021: 27 · 2020: 34 · 2019: 24 · 2018: 25 · 2017: 27 · 2016: 33 · 2015: 31 · 2014: 20 · 2013: 28 · 2012: 24
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Medical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- plasma triglycerides, insulin resistance, type 2 diabetes, dyslipidemia, VLDL secretion, apolipoprotein B, hepatic triglyceride metabolism, cholesteryl ester transfer protein, HDL cholesterol, small dense LDL, microsomal triglyceride transfer protein, hepatic de novo lipogenesis, lipolysis, cardiovascular disease, lipid-lowering therapy
- MeSH terms
- Adipose Tissue, Animals, Apolipoproteins B, Cholesterol, Chylomicrons, Diabetes Mellitus, Type 2, Fatty Acids, Humans, Insulin Resistance, Lipoproteins, Lipoproteins, HDL, Lipoproteins, VLDL, Liver, Models, Biological, Triglycerides, Apolipoprotein A-I, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review